K911958 is an FDA 510(k) clearance for the CYTOCLONE A & B EIA. Classified as Reagents, Clostridium Difficile Toxin (product code LLH), Class I - General Controls.
Submitted by Cambridge Biotech Corp. (Worcester, US). The FDA issued a Cleared decision on July 30, 1991 after a review of 88 days - a notably fast clearance cycle.
This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.2660 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Cambridge Biotech Corp. devices